On April 2, 2025, Sunshine Biopharma Inc. entered into a securities purchase agreement, issuing 928,404 shares at $2.07 each and pre-funded warrants, raising approximately $1.8 million for general corporate purposes. The offering closed on April 3, 2025, with an 8% fee paid to the placement agent.